NouvSoma002-01

N/A

Report date: 2025/08/01 20:01:42

Base Information

Drug NameNouvSoma002-01
Drug Alias NameiPSC-derived ExosomesiPSC-EVsNouvSoma002-01
ClassificationBiologics > Exosomes > Stem cell-derived exosomes
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMoyamoya Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesiRegene Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMoyamoya Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A